Antiretroviral Drug Market Share 2022 Growth Challenges, Opportunities and Future Trends 2028
The global antiretroviral drug market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Antiretrovirals are the class of drugs that are considered to be effective against the incidences of a retrovirus such as to treat HIV, in particular. The major factors that are primarily attributed to the growth of these drugs include the rising prevalence and burden of HIV infections all over the globe. According to the US Department of Health & Human Services, there were nearly 37.9 million people globally living with HIV/AIDS in 2018. An estimated 1.7 million individuals globally became newly infected with HIV in 2018.
To Request a Sample of our Report on Antiretroviral Drug
Market: https://www.omrglobal.com/request-sample/antiretroviral-drug-market-share
Another key trends that drive the market growth include the increasing
investment in the R&D of such drugs along with the increase in the
availability of novel drugs with improved drug efficacy. These drugs are
available in number of categories that majorly include integrase inhibitors,
protease inhibitors, nucleoside reverse transcriptase inhibitors (NRTIs),
non-nucleoside reverse transcriptase inhibitors (NNRTIs), and others. Among all
these, Nucleoside Reverse Transcriptase Inhibitors (NRTIs) are likely to drive
the market growth during the forecast period. Currently, antiretrovirals are
considered to be the base of HIV/AIDS treatment, since there is no solid cure
or a preventive vaccine available for HIV. In the case of a non-resistant
strain of HIV, antiretroviral treatment can restrain the replication of HIV in
the majority of cases. Thus, the presence of a huge patient pool demands
anti-retroviral drugs for the treatment which is projected to drive the growth
of the market during the forecast period.
Market Coverage
·
The market number available for – 2021-2028
·
Base year- 2021
·
Forecast period- 2022-2028
Segment Covered-
·
By Drug Class
Regions covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape: Bristol-Myers Squibb Co., Gilead Sciences,
Inc., and Merck & Co., Inc., among others.
(Get 15% Discount on Buying this Report)
A
full Report of Antiretroviral Drug Market is Available @ https://www.omrglobal.com/industry-reports/antiretroviral-drug-market-share
Global Antiretroviral Drug Market Report by Segment
By Drug Class
·
Protease Inhibitors
·
Integrase Inhibitors
·
Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
·
Non-Nucleoside Reverse Transcriptase Inhibitors
(NNRTIs)
·
Others
Global Antiretroviral Drug Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment